IP Library Granted Patent US 7,393,859
Granted Patent B2
US 7,393,859 · App. 10/848,893 · Granted Jul 1, 2008

Amide substituted imidazoquinolines

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,393,859
App. No.
10/848,893
Granted
Jul 1, 2008
Kind
B2
Abstract

Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain amide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Claims (11)

1. A compound of the formula (Ie):

wherein

R 1 is —C 2-4 alkyl—NR 3 —CO—R 4 ;

R 2 is selected from the group consisting of hydrogen, C 1-4 alkyl, and C 1-4 alkyl—O—C 1-4 alkyl;

R 3 is hydrogen;

R 4 is C 1-8 alkyl; and

n is 0;

or a pharmaceutically acceptable salt thereof.

2. The compound or salt of claim 1 wherein R 2 is C 1-4 alkyl—O—C 1-4 alkyl, and R 4 is cyclohexyl.

3. A pharmaceutical composition comprising a therapeutically effective amount of a compound of claim 1 in combination with a pharmaceutically acceptable carrier.

4. A pharmaceutical composition comprising a therapeutically effective amount of a compound of claim 2 in combination with a pharmaceutically acceptable carrier.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2011
From: COLEY PHARMACEUTICAL GROUP, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 026167/0103 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2007
From: 3M COMPANY; 3M INNOVATIVE PROPERTIES COMPANY
To: COLEY PHARMACEUTICAL GROUP, INC.
Reel/Frame 019965/0551 →